Overview A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis Status: Completed Trial end date: 2009-04-09 Target enrollment: Participant gender: Summary The purpose of the study is to explore the efficacy and safety of SUN13834 vs placebo in adult participants with atopic dermatitis. Phase: Phase 2 Details Lead Sponsor: Daiichi Sankyo Inc.Daiichi Sankyo, Inc.